Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.04 per share
-
Shares outstanding
-
106,324,269
-
Total 13F shares
-
11,189,723
-
Share change
-
+51,917
-
Total reported value
-
$97,062,000
-
Price per share
-
$8.68
-
Number of holders
-
32
-
Value change
-
-$3,472,541
-
Number of buys
-
14
-
Number of sells
-
19
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) as of Q4 2015
As of 31 Dec 2015,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,189,723 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, FMR LLC, JENNISON ASSOCIATES LLC, BAKER BROS. ADVISORS LP, MILLENNIUM MANAGEMENT LLC, JANUS CAPITAL MANAGEMENT LLC, Viking Global Investors LP, Redmile Group, LLC, Clearbridge Investments, LLC, and HIGHLAND CAPITAL MANAGEMENT LP.
This page lists
32
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.